Suanfarma Suanfarma

X

Find the latest news about AffyImmune Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
AffyImmune Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
22 Strathmore Road Natick, MA 01760 (617) 699-1965
Telephone
Telephone
(617) 699-1965
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240408382880/en

BUSINESSWIRE
08 Apr 2024

https://www.businesswire.com/news/home/20240319937182/en

BUSINESSWIRE
19 Mar 2024

https://www.businesswire.com/news/home/20240305694717/en

BUSINESSWIRE
05 Mar 2024

https://www.businesswire.com/news/home/20240220020664/en

BUSINESSWIRE
20 Feb 2024

https://www.prnewswire.com/news-releases/affyimmune-therapeutics-adds-serial-entrepreneur-robert-forrester-to-board-of-directors-301636032.html#:~:text=NATICK%2C%20Mass.%2C%20Sept.,to%20its%20Board%20of%20Directors.

PRNEWSWIRE
29 Sep 2022

https://www.prnewswire.com/news-releases/affyimmune-therapeutics-announces-hiring-of-dr-sonal-gupta-as-senior-vice-president-and-head-of-clinical-development-301531879.html

PRNEWSWIRE
25 Apr 2022

https://www.fiercebiotech.com/biotech/affyimmune-raises-30m-to-reduce-toxicity-increase-longevity-car-t-cells-solid-tumors

K. LaHucik FIERCEBIOTECH
08 Oct 2021

https://www.prnewswire.com/news-releases/affyimmune-therapeutics-aic100-granted-fast-track-designation-for-treating-thyroid-cancer-301292870.html

PRNEWSWIRE
17 May 2021

https://www.prnewswire.com/news-releases/affyimmune-therapeutics-aic100-granted-fast-track-designation-for-treating-thyroid-cancer-301292870.html

PRNEWSWIRE
17 May 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY